Cardiac adverse events in bisphosphonate and teriparatide users: An international pharmacovigilance study
Author:
Publisher
Elsevier BV
Subject
Histology,Physiology,Endocrinology, Diabetes and Metabolism
Reference30 articles.
1. First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC myeloma IX): a randomised controlled trial;Morgan;Lancet,2010
2. HORIZON pivotal fracture trial. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis;Black;N. Engl. J. Med.,2007
3. Zoledronic acid and clinical fractures and mortality after hip fracture;Lyles;N. Engl. J. Med.,2007
4. Alendronate affects calcium dynamics in cardiomyocytes in vitro;Kemeny-Suss;Vascul. Pharmacol.,2009
5. Effects of zoledronate on cancer, cardiac events, and mortality in osteopenic older women;Reid;J. Bone Miner. Res.,2020
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Adverse events associated with teriparatide: a real-world disproportionality analysis of the FDA adverse event reporting system (FAERS);Expert Opinion on Drug Safety;2024-08-19
2. Cardiovascular Safety of Romosozumab vs PTH Analogues for Osteoporosis Treatment: A Propensity-Score-Matched Cohort Study;The Journal of Clinical Endocrinology & Metabolism;2024-03-14
3. Research progress of targeted therapy regulating Th17/Treg balance in bone immune diseases;Frontiers in Immunology;2024-01-30
4. Characterization of a Unique Spontaneous Calcifying Cell Line (CJ): a Novel Tool for the Study of Ectopic Calcification;2024-01-05
5. Bisphosphonates and Cardiac Arrhythmia: An Analysis of the FDA Adverse Event Reporting System (FAERS);2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3